Valuation (67%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 44.86 | 18.54 |
PEG Ratio (TTM) | 3.31 | 6.26 |
P/S Ratio (TTM) | 0.86 | 1.30 |
P/B Ratio (TTM) | 2.15 | 5.13 |
P/FCF Ratio (TTM) | 11.38 | 8.07 |
Price to 5YR AVG Earnings Ratio | 20.74 | 24.68 |
Price to 5YR AVG FCF Ratio | 12.71 | 21.90 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.54% | 5.21% |
ROE (TTM) | 4.95% | 6.30% |
Net Profit Margin (TTM) | 1.92% | 5.09% |
ROIC 5YR AVG | 9.66% | 15.10% |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -141.99% | -1.39% | -6.99% |
Revenue | 1.36% | 6.40% | 10.83% |
Net Income | -141.60% | -0.83% | -7.93% |
Cash Flow | 93.45% | 34.97% | 32.57% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.27 | 2.09 |
Quick Ratio (TTM) | 0.65 | 1.21 |
D/E Ratio (TTM) | 0.59 | 2.89 |
Interest Coverage (TTM) | 41.97 | 19.52 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 3.45 | 3.56 |
LTL to 5YR AVG FCF | 0.28 | 5.91 |
Shares Outstanding Growth 5YR AVG | -1.42% | 0.13% |